Please provide your email address to receive an email when new articles are posted on . The U.S. Preventive Services Task Force recommended statins for the primary prevention of CVD in patients aged ...
SAN DIEGO -- Bempedoic acid (Nexletol) prevented cardiovascular events in high-risk, statin-intolerant patients who had not yet had an event, a subgroup analysis from the CLEAR Outcomes trial ...
Treating high-risk, statin-intolerant patients without a prior cardiovascular event with bempedoic acid (Nexletol; Esperion) leads to a significant reduction in their risk of atherosclerotic ...
(UPDATED) A new analysis is challenging the use of statin therapy for the primary prevention of cardiovascular disease, with researchers arguing that the lipid-lowering drugs should be more carefully ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results